Clinical trial
Vaccine Therapy in Treating Patients With Unresected Stage III or Stage IV…
NCT00107159 · Jonsson Comprehensive Cancer Center, Other · Completed
Key facts
| NCT number | NCT00107159 |
|---|---|
| Title | Vaccine Therapy in Treating Patients With Unresected Stage III or Stage IV Melanoma |
| Official title | A Phase II Study Of Matured Dendritic Cells Pulsed Ex Vivo With 3 Melanoma Cell Line Lysates (IDD-3) in Patients With In-Transit or Metastatic Melanoma |
| Lead sponsor | Jonsson Comprehensive Cancer Center, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Melanoma (Skin) |
| Intervention type | Biological |
| Interventions | autologous dendritic cell-allogeneic melanoma tumor cell lysate vaccine |
| Enrollment | 37 |
| Start date | Jan 1, 2005 |
| Completion | Sep 1, 2010 |
| First posted | Apr 6, 2005 |
| Last update posted | Nov 6, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: